Global Chinese Patent Medicine for Bones and Muscles Supply, Demand and Key Producers, 2024-2030

Description

Chinese patent medicine are herbal medicines in Traditional Chinese medicine, modernized into a ready-to-use form such as tablets, oral solutions or dry suspensions, as opposed to herbs that require cooking (hot water extraction). This report focus on Chinese Patent Medicine for Bones and Muscles.

The global Chinese Patent Medicine for Bones and Muscles market size is expected to reach $ 4221 million by 2030, rising at a market growth of 5.0% CAGR during the forecast period (2024-2030).

As an indispensable part of Traditional Chinese medicine (TCM), Chinese patent medicines have played an important role in preventing and treating diseases in China. Since they are easy to use, easy to store, and cost-effective, Chinese patent medicines have been generally accepted and widely used in Chinese clinical practice as a vital medical resource. In recent years, as TCM has developed and it has been accepted around the world, many Chinese patent medicine companies have gained international market access and successfully registered several Chinese patent medicines as over-the-counter (OTC) or prescription drugs in regions and countries that primarily use Western medicine such as the EU, Russia, Canada, Singapore, and Vietnam. Moreover, several Chinese patent medicines have been obtained the US Food and Drug Administration (FDA) approval conducting phase II or III clinical trials in the US.

This report studies the global Chinese Patent Medicine for Bones and Muscles demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Chinese Patent Medicine for Bones and Muscles, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Chinese Patent Medicine for Bones and Muscles that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Chinese Patent Medicine for Bones and Muscles total market, 2019-2030, (USD Million)
Global Chinese Patent Medicine for Bones and Muscles total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Chinese Patent Medicine for Bones and Muscles total market, key domestic companies, and share, (USD Million)
Global Chinese Patent Medicine for Bones and Muscles revenue by player, revenue and market share 2019-2024, (USD Million)
Global Chinese Patent Medicine for Bones and Muscles total market by Type, CAGR, 2019-2030, (USD Million)
Global Chinese Patent Medicine for Bones and Muscles total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Chinese Patent Medicine for Bones and Muscles market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zhongheng Group, Fangsheng Pharmaceutical, Yunnan Baiyao Group, Beijing TRT Group, Pien Tze Huang Pharmaceutical, BaiYunShan Pharmaceutical, China Resources Sanjiu, Yiling Pharmaceutical, Jumpcan Pharmaceutical, Tasly Group, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Chinese Patent Medicine for Bones and Muscles market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Chinese Patent Medicine for Bones and Muscles Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Chinese Patent Medicine for Bones and Muscles Market, Segmentation by Type
    Oral
    Topical
    Others

Global Chinese Patent Medicine for Bones and Muscles Market, Segmentation by Application:
    Hospital
    Pharmacy
    Others

Companies Profiled:
    Zhongheng Group
    Fangsheng Pharmaceutical
    Yunnan Baiyao Group
    Beijing TRT Group
    Pien Tze Huang Pharmaceutical
    BaiYunShan Pharmaceutical
    China Resources Sanjiu
    Yiling Pharmaceutical
    Jumpcan Pharmaceutical
    Tasly Group
    Buchang Pharmaceutical
    Sunflower Pharmaceutical
    Ginwa Enterprise
    KPC Pharmaceutical
    Jiangsu Kanion Pharmaceutical
    Xintian Pharmaceutical
    Henan Lingrui Pharmaceutical

Key Questions Answered
1. How big is the global Chinese Patent Medicine for Bones and Muscles market?
2. What is the demand of the global Chinese Patent Medicine for Bones and Muscles market?
3. What is the year over year growth of the global Chinese Patent Medicine for Bones and Muscles market?
4. What is the total value of the global Chinese Patent Medicine for Bones and Muscles market?
5. Who are the Major Players in the global Chinese Patent Medicine for Bones and Muscles market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Chinese Patent Medicine for Bones and Muscles Introduction
    1.2 World Chinese Patent Medicine for Bones and Muscles Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Chinese Patent Medicine for Bones and Muscles Total Market by Region (by Headquarter Location)
        1.3.1 World Chinese Patent Medicine for Bones and Muscles Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company Chinese Patent Medicine for Bones and Muscles Revenue (2019-2030)
        1.3.3 China Based Company Chinese Patent Medicine for Bones and Muscles Revenue (2019-2030)
        1.3.4 Europe Based Company Chinese Patent Medicine for Bones and Muscles Revenue (2019-2030)
        1.3.5 Japan Based Company Chinese Patent Medicine for Bones and Muscles Revenue (2019-2030)
        1.3.6 South Korea Based Company Chinese Patent Medicine for Bones and Muscles Revenue (2019-2030)
        1.3.7 ASEAN Based Company Chinese Patent Medicine for Bones and Muscles Revenue (2019-2030)
        1.3.8 India Based Company Chinese Patent Medicine for Bones and Muscles Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Chinese Patent Medicine for Bones and Muscles Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030)
    2.2 World Chinese Patent Medicine for Bones and Muscles Consumption Value by Region
        2.2.1 World Chinese Patent Medicine for Bones and Muscles Consumption Value by Region (2019-2024)
        2.2.2 World Chinese Patent Medicine for Bones and Muscles Consumption Value Forecast by Region (2025-2030)
    2.3 United States Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030)
    2.4 China Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030)
    2.5 Europe Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030)
    2.6 Japan Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030)
    2.7 South Korea Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030)
    2.8 ASEAN Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030)
    2.9 India Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030)

3 World Chinese Patent Medicine for Bones and Muscles Companies Competitive Analysis
    3.1 World Chinese Patent Medicine for Bones and Muscles Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Chinese Patent Medicine for Bones and Muscles Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Chinese Patent Medicine for Bones and Muscles in 2023
        3.2.3 Global Concentration Ratios (CR8) for Chinese Patent Medicine for Bones and Muscles in 2023
    3.3 Chinese Patent Medicine for Bones and Muscles Company Evaluation Quadrant
    3.4 Chinese Patent Medicine for Bones and Muscles Market: Overall Company Footprint Analysis
        3.4.1 Chinese Patent Medicine for Bones and Muscles Market: Region Footprint
        3.4.2 Chinese Patent Medicine for Bones and Muscles Market: Company Product Type Footprint
        3.4.3 Chinese Patent Medicine for Bones and Muscles Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: Chinese Patent Medicine for Bones and Muscles Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Chinese Patent Medicine for Bones and Muscles Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Chinese Patent Medicine for Bones and Muscles Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Chinese Patent Medicine for Bones and Muscles Consumption Value Comparison
        4.2.1 United States VS China: Chinese Patent Medicine for Bones and Muscles Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Chinese Patent Medicine for Bones and Muscles Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Chinese Patent Medicine for Bones and Muscles Companies and Market Share, 2019-2024
        4.3.1 United States Based Chinese Patent Medicine for Bones and Muscles Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Chinese Patent Medicine for Bones and Muscles Revenue, (2019-2024)
    4.4 China Based Companies Chinese Patent Medicine for Bones and Muscles Revenue and Market Share, 2019-2024
        4.4.1 China Based Chinese Patent Medicine for Bones and Muscles Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Chinese Patent Medicine for Bones and Muscles Revenue, (2019-2024)
    4.5 Rest of World Based Chinese Patent Medicine for Bones and Muscles Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Chinese Patent Medicine for Bones and Muscles Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies Chinese Patent Medicine for Bones and Muscles Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World Chinese Patent Medicine for Bones and Muscles Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Oral
        5.2.2 Topical
        5.2.3 Others
    5.3 Market Segment by Type
        5.3.1 World Chinese Patent Medicine for Bones and Muscles Market Size by Type (2019-2024)
        5.3.2 World Chinese Patent Medicine for Bones and Muscles Market Size by Type (2025-2030)
        5.3.3 World Chinese Patent Medicine for Bones and Muscles Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
    6.1 World Chinese Patent Medicine for Bones and Muscles Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Pharmacy
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Chinese Patent Medicine for Bones and Muscles Market Size by Application (2019-2024)
        6.3.2 World Chinese Patent Medicine for Bones and Muscles Market Size by Application (2025-2030)
        6.3.3 World Chinese Patent Medicine for Bones and Muscles Market Size Market Share by Application (2019-2030)

7 Company Profiles
    7.1 Zhongheng Group
        7.1.1 Zhongheng Group Details
        7.1.2 Zhongheng Group Major Business
        7.1.3 Zhongheng Group Chinese Patent Medicine for Bones and Muscles Product and Services
        7.1.4 Zhongheng Group Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Zhongheng Group Recent Developments/Updates
        7.1.6 Zhongheng Group Competitive Strengths & Weaknesses
    7.2 Fangsheng Pharmaceutical
        7.2.1 Fangsheng Pharmaceutical Details
        7.2.2 Fangsheng Pharmaceutical Major Business
        7.2.3 Fangsheng Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Services
        7.2.4 Fangsheng Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Fangsheng Pharmaceutical Recent Developments/Updates
        7.2.6 Fangsheng Pharmaceutical Competitive Strengths & Weaknesses
    7.3 Yunnan Baiyao Group
        7.3.1 Yunnan Baiyao Group Details
        7.3.2 Yunnan Baiyao Group Major Business
        7.3.3 Yunnan Baiyao Group Chinese Patent Medicine for Bones and Muscles Product and Services
        7.3.4 Yunnan Baiyao Group Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Yunnan Baiyao Group Recent Developments/Updates
        7.3.6 Yunnan Baiyao Group Competitive Strengths & Weaknesses
    7.4 Beijing TRT Group
        7.4.1 Beijing TRT Group Details
        7.4.2 Beijing TRT Group Major Business
        7.4.3 Beijing TRT Group Chinese Patent Medicine for Bones and Muscles Product and Services
        7.4.4 Beijing TRT Group Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Beijing TRT Group Recent Developments/Updates
        7.4.6 Beijing TRT Group Competitive Strengths & Weaknesses
    7.5 Pien Tze Huang Pharmaceutical
        7.5.1 Pien Tze Huang Pharmaceutical Details
        7.5.2 Pien Tze Huang Pharmaceutical Major Business
        7.5.3 Pien Tze Huang Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Services
        7.5.4 Pien Tze Huang Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Pien Tze Huang Pharmaceutical Recent Developments/Updates
        7.5.6 Pien Tze Huang Pharmaceutical Competitive Strengths & Weaknesses
    7.6 BaiYunShan Pharmaceutical
        7.6.1 BaiYunShan Pharmaceutical Details
        7.6.2 BaiYunShan Pharmaceutical Major Business
        7.6.3 BaiYunShan Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Services
        7.6.4 BaiYunShan Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 BaiYunShan Pharmaceutical Recent Developments/Updates
        7.6.6 BaiYunShan Pharmaceutical Competitive Strengths & Weaknesses
    7.7 China Resources Sanjiu
        7.7.1 China Resources Sanjiu Details
        7.7.2 China Resources Sanjiu Major Business
        7.7.3 China Resources Sanjiu Chinese Patent Medicine for Bones and Muscles Product and Services
        7.7.4 China Resources Sanjiu Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 China Resources Sanjiu Recent Developments/Updates
        7.7.6 China Resources Sanjiu Competitive Strengths & Weaknesses
    7.8 Yiling Pharmaceutical
        7.8.1 Yiling Pharmaceutical Details
        7.8.2 Yiling Pharmaceutical Major Business
        7.8.3 Yiling Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Services
        7.8.4 Yiling Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Yiling Pharmaceutical Recent Developments/Updates
        7.8.6 Yiling Pharmaceutical Competitive Strengths & Weaknesses
    7.9 Jumpcan Pharmaceutical
        7.9.1 Jumpcan Pharmaceutical Details
        7.9.2 Jumpcan Pharmaceutical Major Business
        7.9.3 Jumpcan Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Services
        7.9.4 Jumpcan Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Jumpcan Pharmaceutical Recent Developments/Updates
        7.9.6 Jumpcan Pharmaceutical Competitive Strengths & Weaknesses
    7.10 Tasly Group
        7.10.1 Tasly Group Details
        7.10.2 Tasly Group Major Business
        7.10.3 Tasly Group Chinese Patent Medicine for Bones and Muscles Product and Services
        7.10.4 Tasly Group Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Tasly Group Recent Developments/Updates
        7.10.6 Tasly Group Competitive Strengths & Weaknesses
    7.11 Buchang Pharmaceutical
        7.11.1 Buchang Pharmaceutical Details
        7.11.2 Buchang Pharmaceutical Major Business
        7.11.3 Buchang Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Services
        7.11.4 Buchang Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Buchang Pharmaceutical Recent Developments/Updates
        7.11.6 Buchang Pharmaceutical Competitive Strengths & Weaknesses
    7.12 Sunflower Pharmaceutical
        7.12.1 Sunflower Pharmaceutical Details
        7.12.2 Sunflower Pharmaceutical Major Business
        7.12.3 Sunflower Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Services
        7.12.4 Sunflower Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Sunflower Pharmaceutical Recent Developments/Updates
        7.12.6 Sunflower Pharmaceutical Competitive Strengths & Weaknesses
    7.13 Ginwa Enterprise
        7.13.1 Ginwa Enterprise Details
        7.13.2 Ginwa Enterprise Major Business
        7.13.3 Ginwa Enterprise Chinese Patent Medicine for Bones and Muscles Product and Services
        7.13.4 Ginwa Enterprise Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Ginwa Enterprise Recent Developments/Updates
        7.13.6 Ginwa Enterprise Competitive Strengths & Weaknesses
    7.14 KPC Pharmaceutical
        7.14.1 KPC Pharmaceutical Details
        7.14.2 KPC Pharmaceutical Major Business
        7.14.3 KPC Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Services
        7.14.4 KPC Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 KPC Pharmaceutical Recent Developments/Updates
        7.14.6 KPC Pharmaceutical Competitive Strengths & Weaknesses
    7.15 Jiangsu Kanion Pharmaceutical
        7.15.1 Jiangsu Kanion Pharmaceutical Details
        7.15.2 Jiangsu Kanion Pharmaceutical Major Business
        7.15.3 Jiangsu Kanion Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Services
        7.15.4 Jiangsu Kanion Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
        7.15.5 Jiangsu Kanion Pharmaceutical Recent Developments/Updates
        7.15.6 Jiangsu Kanion Pharmaceutical Competitive Strengths & Weaknesses
    7.16 Xintian Pharmaceutical
        7.16.1 Xintian Pharmaceutical Details
        7.16.2 Xintian Pharmaceutical Major Business
        7.16.3 Xintian Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Services
        7.16.4 Xintian Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
        7.16.5 Xintian Pharmaceutical Recent Developments/Updates
        7.16.6 Xintian Pharmaceutical Competitive Strengths & Weaknesses
    7.17 Henan Lingrui Pharmaceutical
        7.17.1 Henan Lingrui Pharmaceutical Details
        7.17.2 Henan Lingrui Pharmaceutical Major Business
        7.17.3 Henan Lingrui Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Services
        7.17.4 Henan Lingrui Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024)
        7.17.5 Henan Lingrui Pharmaceutical Recent Developments/Updates
        7.17.6 Henan Lingrui Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Chinese Patent Medicine for Bones and Muscles Industry Chain
    8.2 Chinese Patent Medicine for Bones and Muscles Upstream Analysis
    8.3 Chinese Patent Medicine for Bones and Muscles Midstream Analysis
    8.4 Chinese Patent Medicine for Bones and Muscles Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Chinese Patent Medicine for Bones and Muscles Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World Chinese Patent Medicine for Bones and Muscles Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World Chinese Patent Medicine for Bones and Muscles Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World Chinese Patent Medicine for Bones and Muscles Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World Chinese Patent Medicine for Bones and Muscles Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World Chinese Patent Medicine for Bones and Muscles Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World Chinese Patent Medicine for Bones and Muscles Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World Chinese Patent Medicine for Bones and Muscles Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World Chinese Patent Medicine for Bones and Muscles Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key Chinese Patent Medicine for Bones and Muscles Players in 2023
 Table 12. World Chinese Patent Medicine for Bones and Muscles Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global Chinese Patent Medicine for Bones and Muscles Company Evaluation Quadrant
 Table 14. Head Office of Key Chinese Patent Medicine for Bones and Muscles Players
 Table 15. Chinese Patent Medicine for Bones and Muscles Market: Company Product Type Footprint
 Table 16. Chinese Patent Medicine for Bones and Muscles Market: Company Product Application Footprint
 Table 17. Chinese Patent Medicine for Bones and Muscles Mergers & Acquisitions Activity
 Table 18. United States VS China Chinese Patent Medicine for Bones and Muscles Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China Chinese Patent Medicine for Bones and Muscles Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based Chinese Patent Medicine for Bones and Muscles Companies, Headquarters (States, Country)
 Table 21. United States Based Companies Chinese Patent Medicine for Bones and Muscles Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies Chinese Patent Medicine for Bones and Muscles Revenue Market Share (2019-2024)
 Table 23. China Based Chinese Patent Medicine for Bones and Muscles Companies, Headquarters (Province, Country)
 Table 24. China Based Companies Chinese Patent Medicine for Bones and Muscles Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies Chinese Patent Medicine for Bones and Muscles Revenue Market Share (2019-2024)
 Table 26. Rest of World Based Chinese Patent Medicine for Bones and Muscles Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies Chinese Patent Medicine for Bones and Muscles Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies Chinese Patent Medicine for Bones and Muscles Revenue Market Share (2019-2024)
 Table 29. World Chinese Patent Medicine for Bones and Muscles Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World Chinese Patent Medicine for Bones and Muscles Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World Chinese Patent Medicine for Bones and Muscles Market Size by Type (2025-2030) & (USD Million)
 Table 32. World Chinese Patent Medicine for Bones and Muscles Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Table 33. World Chinese Patent Medicine for Bones and Muscles Market Size by Application (2019-2024) & (USD Million)
 Table 34. World Chinese Patent Medicine for Bones and Muscles Market Size by Application (2025-2030) & (USD Million)
 Table 35. Zhongheng Group Basic Information, Manufacturing Base and Competitors
 Table 36. Zhongheng Group Major Business
 Table 37. Zhongheng Group Chinese Patent Medicine for Bones and Muscles Product and Services
 Table 38. Zhongheng Group Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. Zhongheng Group Recent Developments/Updates
 Table 40. Zhongheng Group Competitive Strengths & Weaknesses
 Table 41. Fangsheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 42. Fangsheng Pharmaceutical Major Business
 Table 43. Fangsheng Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Services
 Table 44. Fangsheng Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. Fangsheng Pharmaceutical Recent Developments/Updates
 Table 46. Fangsheng Pharmaceutical Competitive Strengths & Weaknesses
 Table 47. Yunnan Baiyao Group Basic Information, Manufacturing Base and Competitors
 Table 48. Yunnan Baiyao Group Major Business
 Table 49. Yunnan Baiyao Group Chinese Patent Medicine for Bones and Muscles Product and Services
 Table 50. Yunnan Baiyao Group Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. Yunnan Baiyao Group Recent Developments/Updates
 Table 52. Yunnan Baiyao Group Competitive Strengths & Weaknesses
 Table 53. Beijing TRT Group Basic Information, Manufacturing Base and Competitors
 Table 54. Beijing TRT Group Major Business
 Table 55. Beijing TRT Group Chinese Patent Medicine for Bones and Muscles Product and Services
 Table 56. Beijing TRT Group Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. Beijing TRT Group Recent Developments/Updates
 Table 58. Beijing TRT Group Competitive Strengths & Weaknesses
 Table 59. Pien Tze Huang Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 60. Pien Tze Huang Pharmaceutical Major Business
 Table 61. Pien Tze Huang Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Services
 Table 62. Pien Tze Huang Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. Pien Tze Huang Pharmaceutical Recent Developments/Updates
 Table 64. Pien Tze Huang Pharmaceutical Competitive Strengths & Weaknesses
 Table 65. BaiYunShan Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 66. BaiYunShan Pharmaceutical Major Business
 Table 67. BaiYunShan Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Services
 Table 68. BaiYunShan Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. BaiYunShan Pharmaceutical Recent Developments/Updates
 Table 70. BaiYunShan Pharmaceutical Competitive Strengths & Weaknesses
 Table 71. China Resources Sanjiu Basic Information, Manufacturing Base and Competitors
 Table 72. China Resources Sanjiu Major Business
 Table 73. China Resources Sanjiu Chinese Patent Medicine for Bones and Muscles Product and Services
 Table 74. China Resources Sanjiu Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 75. China Resources Sanjiu Recent Developments/Updates
 Table 76. China Resources Sanjiu Competitive Strengths & Weaknesses
 Table 77. Yiling Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 78. Yiling Pharmaceutical Major Business
 Table 79. Yiling Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Services
 Table 80. Yiling Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 81. Yiling Pharmaceutical Recent Developments/Updates
 Table 82. Yiling Pharmaceutical Competitive Strengths & Weaknesses
 Table 83. Jumpcan Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 84. Jumpcan Pharmaceutical Major Business
 Table 85. Jumpcan Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Services
 Table 86. Jumpcan Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 87. Jumpcan Pharmaceutical Recent Developments/Updates
 Table 88. Jumpcan Pharmaceutical Competitive Strengths & Weaknesses
 Table 89. Tasly Group Basic Information, Manufacturing Base and Competitors
 Table 90. Tasly Group Major Business
 Table 91. Tasly Group Chinese Patent Medicine for Bones and Muscles Product and Services
 Table 92. Tasly Group Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 93. Tasly Group Recent Developments/Updates
 Table 94. Tasly Group Competitive Strengths & Weaknesses
 Table 95. Buchang Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 96. Buchang Pharmaceutical Major Business
 Table 97. Buchang Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Services
 Table 98. Buchang Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 99. Buchang Pharmaceutical Recent Developments/Updates
 Table 100. Buchang Pharmaceutical Competitive Strengths & Weaknesses
 Table 101. Sunflower Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 102. Sunflower Pharmaceutical Major Business
 Table 103. Sunflower Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Services
 Table 104. Sunflower Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 105. Sunflower Pharmaceutical Recent Developments/Updates
 Table 106. Sunflower Pharmaceutical Competitive Strengths & Weaknesses
 Table 107. Ginwa Enterprise Basic Information, Manufacturing Base and Competitors
 Table 108. Ginwa Enterprise Major Business
 Table 109. Ginwa Enterprise Chinese Patent Medicine for Bones and Muscles Product and Services
 Table 110. Ginwa Enterprise Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 111. Ginwa Enterprise Recent Developments/Updates
 Table 112. Ginwa Enterprise Competitive Strengths & Weaknesses
 Table 113. KPC Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 114. KPC Pharmaceutical Major Business
 Table 115. KPC Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Services
 Table 116. KPC Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 117. KPC Pharmaceutical Recent Developments/Updates
 Table 118. KPC Pharmaceutical Competitive Strengths & Weaknesses
 Table 119. Jiangsu Kanion Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 120. Jiangsu Kanion Pharmaceutical Major Business
 Table 121. Jiangsu Kanion Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Services
 Table 122. Jiangsu Kanion Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 123. Jiangsu Kanion Pharmaceutical Recent Developments/Updates
 Table 124. Jiangsu Kanion Pharmaceutical Competitive Strengths & Weaknesses
 Table 125. Xintian Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 126. Xintian Pharmaceutical Major Business
 Table 127. Xintian Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Services
 Table 128. Xintian Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 129. Xintian Pharmaceutical Recent Developments/Updates
 Table 130. Xintian Pharmaceutical Competitive Strengths & Weaknesses
 Table 131. Henan Lingrui Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 132. Henan Lingrui Pharmaceutical Major Business
 Table 133. Henan Lingrui Pharmaceutical Chinese Patent Medicine for Bones and Muscles Product and Services
 Table 134. Henan Lingrui Pharmaceutical Chinese Patent Medicine for Bones and Muscles Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 135. Henan Lingrui Pharmaceutical Recent Developments/Updates
 Table 136. Henan Lingrui Pharmaceutical Competitive Strengths & Weaknesses
 Table 137. Global Key Players of Chinese Patent Medicine for Bones and Muscles Upstream (Raw Materials)
 Table 138. Global Chinese Patent Medicine for Bones and Muscles Typical Customers


List of Figures
 Figure 1. Chinese Patent Medicine for Bones and Muscles Picture
 Figure 2. World Chinese Patent Medicine for Bones and Muscles Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Chinese Patent Medicine for Bones and Muscles Total Revenue (2019-2030) & (USD Million)
 Figure 4. World Chinese Patent Medicine for Bones and Muscles Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World Chinese Patent Medicine for Bones and Muscles Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company Chinese Patent Medicine for Bones and Muscles Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company Chinese Patent Medicine for Bones and Muscles Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company Chinese Patent Medicine for Bones and Muscles Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company Chinese Patent Medicine for Bones and Muscles Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company Chinese Patent Medicine for Bones and Muscles Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company Chinese Patent Medicine for Bones and Muscles Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company Chinese Patent Medicine for Bones and Muscles Revenue (2019-2030) & (USD Million)
 Figure 13. Chinese Patent Medicine for Bones and Muscles Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
 Figure 16. World Chinese Patent Medicine for Bones and Muscles Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
 Figure 18. China Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
 Figure 23. India Chinese Patent Medicine for Bones and Muscles Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of Chinese Patent Medicine for Bones and Muscles by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for Chinese Patent Medicine for Bones and Muscles Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for Chinese Patent Medicine for Bones and Muscles Markets in 2023
 Figure 27. United States VS China: Chinese Patent Medicine for Bones and Muscles Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Chinese Patent Medicine for Bones and Muscles Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World Chinese Patent Medicine for Bones and Muscles Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World Chinese Patent Medicine for Bones and Muscles Market Size Market Share by Type in 2023
 Figure 31. Oral
 Figure 32. Topical
 Figure 33. Others
 Figure 34. World Chinese Patent Medicine for Bones and Muscles Market Size Market Share by Type (2019-2030)
 Figure 35. World Chinese Patent Medicine for Bones and Muscles Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Figure 36. World Chinese Patent Medicine for Bones and Muscles Market Size Market Share by Application in 2023
 Figure 37. Hospital
 Figure 38. Pharmacy
 Figure 39. Others
 Figure 40. World Chinese Patent Medicine for Bones and Muscles Market Size Market Share by Application (2019-2030)
 Figure 41. Chinese Patent Medicine for Bones and Muscles Industrial Chain
 Figure 42. Methodology
 Figure 43. Research Process and Data Source

Companies Mentioned

Zhongheng Group
Fangsheng Pharmaceutical
Yunnan Baiyao Group
Beijing TRT Group
Pien Tze Huang Pharmaceutical
BaiYunShan Pharmaceutical
China Resources Sanjiu
Yiling Pharmaceutical
Jumpcan Pharmaceutical
Tasly Group
Buchang Pharmaceutical
Sunflower Pharmaceutical
Ginwa Enterprise
KPC Pharmaceutical
Jiangsu Kanion Pharmaceutical
Xintian Pharmaceutical
Henan Lingrui Pharmaceutical